Business Development Clinical Informatics Manufacturing Market Access Medical Devices and Diagnostics Pre-Clinical (Discovery and Development) Regulatory/Legal Pharma Logistics

Filter Categories

Business Development Clinical Informatics Manufacturing Market Access Medical Devices and Diagnostics Pre-Clinical (Discovery and Development) Regulatory/Legal Pharma Logistics

Novartis' Jennifer Sheng on Solubility Modelling & the Future of Solubilisation

Add bookmark

Andrea Charles
12/10/2012

Novartis' Jennifer Sheng on Solubility Modelling & the Future of Solubilisation

Add bookmark

By: Andrea Charles, Andrea Charles 12/10/2012

Poor solubility is an obvious barrier to advancing potentially efficacious drug candidates. In this interview Jennifer Sheng, Fellow at Novartis, discusses the most efficient approaches for measuring solubility, why solubility remains a critical challenge in formulation development and how solubility modelling can reduce the R&D timeline. [inlinead] Have Your Say Rate this feature and give us your feedback in the comments section below

Tags: solubility improving solubility formulation development Novartis Jennifer Sheng solubility modelling efficacious drug candidates

Upcoming Events

Pharmaceutical Launch Excellence Summit

2 - 3 December, 2025

UK

Register Now View Agenda View Event

Pharmaceutical Launch Excellence Summit

SmartLab Exchange Europe

23 - 24 February 2026

Amsterdam

Register Now View Agenda View Event

SmartLab Exchange Europe

Pharma Contract Manufacturing

23 - 25 March 2026

Germany

Register Now View Agenda View Event

Pharma Contract Manufacturing

SmartLab Exchange USA

April 21 - 22, 2026

Philadelphia, USA

Register Now View Agenda View Event

SmartLab Exchange USA

Follow Us

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

A post-pandemic 3D view of the patient and supply journey

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

Recommended